sarcosine has been researched along with Basal Ganglia Diseases in 1 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CY | 1 |
| Liang, SY | 1 |
| Chang, YC | 1 |
| Ting, SY | 1 |
| Kao, CL | 1 |
| Wu, YH | 1 |
| Tsai, GE | 1 |
| Lane, HY | 1 |
1 trial available for sarcosine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzoates; Chronic Disease; Cognition; D-Amino- | 2017 |